COST-EFFECTIVENESS MODEL OF PERTUZUMAB IN COMBINATION WITH TRASTUZUMAB AND DOCETAXEL COMPARED WITH TRASTUZUMAB IN COMBINATION WITH DOCETAXEL FOR THE 1ST LINE TREATMENT OF HER2+METASTATIC BREAST CANCER IN COLOMBIA

被引:1
作者
Saenz, Ariza S. A. [1 ]
机构
[1] Prod Roche, Bogota, Colombia
关键词
D O I
10.1016/j.jval.2014.08.2258
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN100
引用
收藏
页码:A631 / A631
页数:1
相关论文
empty
未找到相关数据